ClinicalTrials.govpublic full text
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
brain cancer, glioblastoma, metastatic cancer, leptomeningeal metastasis, recurrent glioblastoma, trastuzumab deruxtecan, t-dxd, 22-208, memorial sloan kettering cancer center, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879573
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.